# Oncological Safety of Spleen Preservation in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)

> **NCT07157605** · — · RECRUITING · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 94 (estimated)

## Conditions studied

- Pancreatic Cancer Resectable
- Pancreatectomy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07157605
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-28
- **Primary completion:** 2026-01-01
- **Final completion:** 2031-01-01
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2025-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07157605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07157605, "Oncological Safety of Spleen Preservation in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT07157605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*